Additionally, PARG gene silencing may regulate the phosphorylation level of proteins to stabilize the expression of Wnt2b, possibly inhibiting the ability of Wnt/β-catenin pathway to drive lung cancer progression as shown in the schematic model in Figure 6. The gene discussed is WNT2B; the disease is lung cancer.